Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Good time to announced a 10b5-1 plan by directors

"A way to rectify that, IMO, and something that I think would provide a SIGNIFICANT signal to the market that these recent announcments and upcoming ones represent a turning of the page/corner is for these 3 historically tone deaf directors to file a 10b5-1 plan establishing that they will be consistent and significant buyers of PTSC stock on the open market.

At this point, they can't buy due to the yet to be filed 10q. But as soon as that's out, they should be unencumbered. And filing such a plan, detaches them from future "quiet periods" as it states up front what and when they will buy and sell and puts in on an established schedule that, regardless of whether they have inside info at a particular time, still allows them to buy shares if done as established in the plan . For them to do so in conjunction with or right after the 10q would be a HUGE boost toward supporting the share price and would lead to a change in perspective from the market, even without dollar figures tied to license announcements or results of the Markman being known."

I don't believe the BOD is tone deaf as you state because they were clearly following shareholder outcries to reinvest the license fees prior to when they went on a shopping spree for companies "with potential" to fill out their umbrella strategy etc.

Otherwise -AGREED! -Thumbs UP!

Share
New Message
Please login to post a reply